2023年5月1日,美国微生物学会官方期刊《Journal of Virology》在线发表了南方医科大学荣知立和暨南大学病原微生物研究院张其威团队的最新研究成果,论文题为“Generation of Human Embryonic Stem Cell-Derived Lung Organoids for Modeling Infection and Replication Differences between Human Adenovirus Types 3 and 55 and Evaluating Potential Antiviral Drugs”。该研究建立了人腺病毒的气道类器官和肺泡类器官感染模型,揭示了人55型腺病毒引起高致病性的机制,并利用该类器官感染模型评估了西多福韦(Cidofovir)抗腺病毒的良好效果。[attach]3166[/attach]
[attach]3165[/attach]
FIG 4 HAdV-55-GFP infects more AT2 cells than HAdV-3-GFP in hALOs.
[attach]3167[/attach]
FIG 5 The virus life cycles of wild type HAdV-3 and -55 in hAWOs.
[attach]3168[/attach]
FIG 6 Cidofovir effectively inhibits the replication of HAdV-3 and HAdV-55 isolates in lung organoid models.
本研究得到了国家重点研发计划项目、国家自然科学基金、广东省自然科学基金等支持。
参考文献:Shanshan Zhao#, Xiaowei Wu#, Zhihong Tan, Yi Ren, Lian Li, JunxianOu, Ying Lin, Hongbin Song, Liqiang Feng, Donald Seto, Jianguo Wu, Qiwei Zhang* and Zhili Rong*. "Generation of Human Embryonic Stem Cell-Derived Lung Organoids for Modeling Infection and Replication Differences between Human Adenovirus Types 3 and 55 and Evaluating Potential Antiviral Drugs." Journal of Virology. 2023 May 1;e0020923. doi: 10.1128/jvi.00209-23.https://journals.asm.org/doi/abs/10.1128/jvi.00209-23